Roche SARS-CoV-2 Molecular Test Granted FDA EUA
Roche has announced that the U.S. FDA has granted EUA for the cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System.
Read MorePosted by Chris Wolski | Jun 18, 2021 | Covid 19, Molecular Diagnostics, POC Rapid Assays |
Roche has announced that the U.S. FDA has granted EUA for the cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System.
Read MorePosted by Melanie Hamilton-Basich | Jun 18, 2021 | Sexually Transmitted Diseases |
The campaign “My test, my way” is coordinated with the support of the CDC and seeks to encourage Latinos and Latinas of all ages to get tested for HIV.
Read MorePosted by Chris Wolski | Jun 15, 2021 | Covid 19 |
A U.S. clinical trial of a COVID-19 rapid test confirmed negative results were 100% (95% CI, 88.4%-100.0%).
Read MorePosted by Melanie Hamilton-Basich | Jun 15, 2021 | Covid 19 |
Researchers discovered commercially available PCR tests can withstand the freeze-drying process, making them shelf-stable for up to 30 days and 122 degrees Fahrenheit, without sacrificing sensitivity and accuracy.
Read MorePosted by Chris Wolski | Jun 15, 2021 | Covid 19, Emerging & Zoonotic Diseases, POC Rapid Assays |
Pandemic preparedness requires long-term investments in disease surveillance, diagnostics, therapeutics, and vaccine research.
Read More